Tikosyn (Avera McKennan Hospital)


Welcome to the PulseAid listing for the Tikosyn drug offered from Avera McKennan Hospital. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Avera McKennan Hospital
NON-PROPRIETARY NAME: dofetilide
SUBSTANCE NAME: DOFETILIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiarrhythmic [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-06-28
END MARKETING DATE: 0000-00-00


Tikosyn HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTikosyn from Avera McKennan Hospital
LABELER NAME: Avera McKennan Hospital
DEA SCHEDULE:
ACTIVE STRENGTH: 0.125(mg/1)
START MARKETING DATE: 2016-06-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69189-5800_e5f28d83-d575-4c10-af66-84c5535f98f7
PRODUCT NDC: 69189-5800
APPLICATION NUMBER: NDA020931

Other DOFETILIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalTikosyn
Greenstone LLCDofetilide
Mayne Pharma Inc.Dofetilide
Pfizer Laboratories Div Pfizer IncTikosyn